A detailed history of Polar Asset Management Partners Inc. transactions in Repligen Corp stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 3,900 shares of RGEN stock, worth $555,477. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,900
Holding current value
$555,477
% of portfolio
0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.79 - $167.35 $467,181 - $652,665
3,900 New
3,900 $580,000
Q3 2023

Nov 14, 2023

SELL
$138.78 - $176.51 $957,582 - $1.22 Million
-6,900 Reduced 62.16%
4,200 $667,000
Q2 2023

Aug 14, 2023

SELL
$138.42 - $180.31 $3.45 Million - $4.49 Million
-24,900 Reduced 69.17%
11,100 $1.57 Million
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $5.55 Million - $7.13 Million
36,000 New
36,000 $6.06 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.9B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Polar Asset Management Partners Inc. Portfolio

Follow Polar Asset Management Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Polar Asset Management Partners Inc. with notifications on news.